SEC Form 4 · accession 0001209191-17-035372
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Earl R Lewis
Director
Period of report
May 23, 2017
Accepted (ET)
May 25, 2017 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 23, 2017 | P | 5,000 | $2.39 | A | 428,012 | D | |
| Common StockF3 | May 24, 2017 | P | 5,000 | $2.37 | A | 433,012 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $2.37 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 404,762 shares of common stock held by the Reporting Person.
- F3Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 409,762 shares of common stock held by the Reporting Person.
Remarks
This form has been signed under power of attorney.